Pharma Industry News

PARIS, Dec. 4, 2008 – BioAlliance Pharma SA (Euronext Paris: BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that it had held a special information and...
NEW YORK, Dec. 3, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. today announced that it has been notified of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) of Toronto, Canada, a private investment company. Forest...
Company to Focus on Expanding Contract Manufacturing Operations AUSTIN, Texas--(BUSINESS WIRE)--Dec 3, 2008 - As part of its ongoing restructuring, Introgen Therapeutics, Inc. (NASDAQ:INGN), today announced that the company has elected to file...
2008 Anticipated Non-GAAP EPS Range of $3.28 to $3.32, Excluding Certain Items; 2008 GAAP EPS Range of $3.45 to $3.55 2009 Anticipated Non-GAAP EPS Range of $3.15 to $3.30, Excluding Certain Items; 2009 GAAP EPS Range of $2.95 to $3.17 2009...
RANCHO CORDOVA, Calif., December 03, 2008 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. , a leading supplier of innovative products and services that process and store adult stem cells, said today that William Osgood, Ph.D. has reached an agreement...
LONDON and PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today that it is waiving a condition relating to a pending lawsuit in the previously announced tender offer to purchase all of the outstanding shares of common stock...
Abbott, Medtronic and Stryker YouTube videos fail to include required product warning statements BOSTON (December 3, 2008) – Pharmaceutical and medical device companies are illegally advertising their products on YouTube, the Prescription...
Analysis: What can we learn from drug marketing efficiency? LONDON, Dec. 2, 2008-With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients' safety is being compromised, warns a study...
ROCKVILLE, Md., Dec. 2, 2008--The FDA has posted on its web site questions and answers on ESA medication guides. Questions and Answers on Medication Guides for Erythropoiesis-Stimulating Agents (ESAs) Epoetin alfa (marketed as Procrit,...
CHICAGO, Dec. 2, 2008—Contrary to the perception of some patients and physicians, there is no evidence that brand-name drugs are clinically superior to their generic counterparts, according to an article in the December 3 issue of JAMA, which...
ST. PAUL, Minn., Dec. 1, 2008- A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child's risk of developing autism. The preliminary research is published in the December 2, 2008,...
CHICAGO, Nov. 25, 2008—An analysis of randomized trials indicates that use of inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease (COPD) does not improve the rate of survival after one year, but is associated...
SAN MATEO, Calif., November 21, 2008 /PRNewswire/ -- Just three days after the JUPITER trial results were presented at the American Heart Association meeting and simultaneously published online by the New England Journal of Medicine, an AlphaDetail...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 20, 2008 - Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections...
CHICAGO, Nov. 18, 2008—An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs),...
JERUSALEM--(BUSINESS WIRE)--Nov 19, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its...
BETHESDA, Md., Nov. 18, 2008-In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to...
New guideline looks at effectiveness of drugs used to treat depressive disorders PHILADELPHIA--(BUSINESS WIRE)--No substantial differences in efficacy or quality of life were found among “second-generation” antidepressants used to treat...
Side Effects Examined in First "Real World" Study Since Industry-Sponsored Clinical Trials SEATTLE--(BUSINESS WIRE)--For smokers interested in quitting tobacco with the use of varenicline (marketed as Chantix), telephone counseling may make it...
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nov 17, 2008 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that the company has been awarded a $150,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health...
More...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
December 2, 2008
Audience: Hematological and Nephrological healthcare professionals, hospital risk managers [Posted 12/02/2008] FDA has received...
November 24, 2008
Audience: Neurological healthcare professionals[Posted 11/24/2008] FDA is investigating new preliminary data regarding a...
November 20, 2008
Audience: Consumers, endocrinological healthcare professionals [Posted 11/20/2008] Animas Corporation and FDA informed consumers...
November 17, 2008
Audience: Consumers, dermatologists, pharmacists, other healthcare professionals[Posted 11/17/2008] CSI USA Inc. and FDA informed...
More...
Latest Drug Information Updates

Promacta
Promacta (eltrombopag) is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura.

Banzel
Banzel (rufinamide) is a triazole derivative antiepileptic drug for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome.

Apriso
Apriso (mesalamine) is a once-daily, locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults.

LoSeasonique
LoSeasonique is a lower-dose, extended-cycle oral contraceptive indicated for the prevention of pregnancy.

Acanya
Acanya (benzoyl peroxide and clindamycin phosphate) is a topical antibacterial and antibiotic combination for the treatment of acne.

Toviaz
Toviaz (fesoterodine fumarate) is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Vimpat
Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial onset seizures in adults with epilepsy.

Astepro
Astepro (azelastine) is a nasal antihistamine for the treatment of seasonal allergic rhinitis.

Rapaflo
Rapaflo (silodosin) is an alpha(1)- adrenoreceptor antagonist for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate.

Cinryze
Cinryze is a C1-esterase inhibitor indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).

Akten
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

More...